Stock Code: 600383 | Stock Short Name: Gemdale | Announcement No.: 2021-069 |
Gemdale Corporation
The Science of Living
Announcement on Completion of Private Fund Filing for the Subscribed Private Fund
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the announcement, and bear individual and joint responsibility for the truthfulness, accuracy and completeness of the contents.
Gemdale Corporation (hereinafter referred to as the "Company") held the 24th meeting of the Ninth Board of Directors on September 8, 2021, in which The Proposal on Participating in the Subscription of Qiming Venture Capital's RMB VII Fund Units was reviewed and approved. The Board of Directors agreed that the Company, as a limited partner, should subscribe for the shares of Hangzhou Qiming Rongjing Equity Investment Partnership (Limited Partnership) (hereinafter referred to as the "Target Fund") with its own capital of RMB30 million. For details, please refer to the Announcement on Subscription of Private Fund Tranches (announcement No.: 2021-051) published by the Company on September 10, 2021 through the designated media, such as China Securities Journal, Shanghai Securities News, Securities Times and the website of Shanghai Stock Exchange (www.sse.com.cn).
On September 30, 2021, the Target Fund completed the establishment registration at the Market Supervision Administration of Gongshu District, Hangzhou City, with the business registration name of Hangzhou Qiming Rongjing Equity Investment Partnership (Limited Partnership).
On November 1, 2021, the Company's wholly-owned subsidiary 拉萨稳裕企业管理有限公司 (Lhasa Wenyu Enterprise Management Co., Ltd.*, hereinafter referred to as the "Lhasa Wenyu") entered into Hangzhou Qiming Rongjing Equity Investment Partnership (Limited Partnership) Cooperation Agreement, pursuant to which Lhasa Wenyu as a limited partner subscribed for a capital contribution of RMB30 million in the Target Fund.
On December 6, 2021, the Company received the notice from the Executive Partner, Suzhou Qikun Venture Capital Partnership (Limited Partnership), stating that the Target Fund has completed the filing with the Asset Management Association of China according to the Securities Investment Funds Law and the Interim Measures for the Supervision and Administration of Private Investment Funds and other relevant laws and regulations, and obtained the Private Investment Fund Filing Certificate. The basic information of
the Target Fund and the filing details are as follows:
I. Basic information
Name: Hangzhou Qiming Rongjing Equity Investment Partnership (Limited Partnership)
Type: Limited Partnership
Unified social credit code: 91330103MA2KL0R138
Date of inception: September 30, 2021
Registered address: Room 305, SDIC Building, 398 Shaoxing Road, Gongshu District, Hangzhou City, Zhejiang Province
Executive Partner: Suzhou Qikun Venture Capital Partnership (Limited Partnership)
Scope of business: general item: equity investment, venture capital(limited to invest in unlisted companies) (except for the items subject to approval according to law, business activities shall be carried out pursuant to the business license independently according to law).
II. Filing information of the Target Fund
Fund Name: Hangzhou Qiming Rongjing Equity Investment Partnership (Limited Partnership)
Name of Manager: Suzhou Qiyuan Equity Investment Management Partnership (Limited Partnership)
Filing code: STD328
This announcement is hereby made.
The Board of Directors of Gemdale Corporation
December 8, 2021
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Gemdale Corporation published this content on 08 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 December 2021 09:11:08 UTC.